These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11544429)

  • 1. Uricosuric effect of losartan in patients with renal transplants.
    Kamper AL; Nielsen AH
    Transplantation; 2001 Aug; 72(4):671-4. PubMed ID: 11544429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA.
    Schmidt A; Gruber U; Böhmig G; Köller E; Mayer G
    Nephrol Dial Transplant; 2001 May; 16(5):1034-7. PubMed ID: 11328912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertension.
    Puig JG; Mateos F; Buño A; Ortega R; Rodriguez F; Dal-Ré R
    J Hypertens; 1999 Jul; 17(7):1033-9. PubMed ID: 10419078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipients.
    Minghelli G; Seydoux C; Goy JJ; Burnier M
    Transplantation; 1998 Jul; 66(2):268-71. PubMed ID: 9701277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.
    Würzner G; Gerster JC; Chiolero A; Maillard M; Fallab-Stubi CL; Brunner HR; Burnier M
    J Hypertens; 2001 Oct; 19(10):1855-60. PubMed ID: 11593107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of the addition of losartan on uric acid metabolism in patients receiving indapamide.
    Nikas S; Rizos E; Milionis H; Bairaktari E; Kalaitzidis R; Siamopoulos K; Elisaf M
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):289-91. PubMed ID: 11881040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome.
    Masajtis-Zagajewska A; Majer J; Nowicki M
    J Renin Angiotensin Aldosterone Syst; 2021; 2021():2214978. PubMed ID: 34527078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of angiotensin II receptor blockade with losartan on systemic blood pressure and renal and extrarenal prostaglandin synthesis in women with essential hypertension.
    Smith MC; Barrows S; Meibohm A; Shahinfar S; Simpson RL; Weigel K; Dunn MJ
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1177-83. PubMed ID: 8998251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
    Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y
    Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
    Naritomi H; Fujita T; Ito S; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan].
    Cice G; Ferrara L; Tagliamonte E; Russo PE; Di Benedetto A; Iacono A
    Cardiologia; 1999 Dec; 44(12):1071-6. PubMed ID: 10687258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of left ventricular hypertrophy by AT1 receptor blockade in renal transplant recipients.
    Klingbeil AU; Müller HJ; Delles C; Fleischmann E; Schmieder RE
    Am J Hypertens; 2000 Dec; 13(12):1295-300. PubMed ID: 11130774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Losartan vs. amlodipine treatment in elderly oncologic hypertensive patients: a randomized clinical trial.
    Motta M; Russo C; Vacante M; Liardo RL; Reitano F; Cammalleri L; Costanzo M; Benfatto G; Frazzetto P; Mondati E; Malaguarnera M; Pennisi G
    Arch Gerontol Geriatr; 2011; 53(1):60-3. PubMed ID: 20569998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To study the efficacy of Losartan on urinary uric acid excretion in Thiazide induced hyperuricemic and hypertensive patients.
    Khan M; Khan RA; Islam F; Laghari J; Jamali SN
    Pak J Pharm Sci; 2011 Oct; 24(4):583-7. PubMed ID: 21959825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective study.
    Zürcher RM; Bock HA; Thiel G
    Nephrol Dial Transplant; 1994; 9(5):548-51. PubMed ID: 8090336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.
    Gansevoort RT; de Zeeuw D; Shahinfar S; Redfield A; de Jong PE
    J Hypertens Suppl; 1994 Jul; 12(2):S37-42. PubMed ID: 7965264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist therapy in hypertensive renal transplant recipients.
    Kim W; Lee S; Kang SK; Yu HC; Cho BH; Park SK
    Transplant Proc; 2002 Dec; 34(8):3223-4. PubMed ID: 12493427
    [No Abstract]   [Full Text] [Related]  

  • 19. Beneficial effect of switching from a combination of angiotensin II receptor blockers other than losartan and thiazides to a fixed dose of losartan/hydrochlorothiazide on uric acid metabolism in hypertensive patients.
    Ohshiro K; Sakima A; Nakada S; Kohagura K; Yamazato M; Tana T; Ohya Y
    Clin Exp Hypertens; 2011; 33(8):565-70. PubMed ID: 21958001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin II receptor blockade on renal disease progression in patients with non-diabetic chronic renal failure.
    Mora-Macía J; Cases A; Calero F; Barceló P
    Nephrol Dial Transplant; 2001; 16 Suppl 1():82-4. PubMed ID: 11369829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.